Gilad Oren 4
4 · Aprea Therapeutics, Inc. · Filed Oct 15, 2024
Insider Transaction Report
Form 4
Gilad Oren
DirectorPresident/CEO
Transactions
- Purchase
Common Stock
2024-10-10$2.54/sh+150$381→ 331,645 total - Purchase
Common Stock
2024-10-14$2.59/sh+1,000$2,590→ 332,645 total
Holdings
- 1,200(indirect: By Daughter)
Common Stock
- 600(indirect: By Son)
Common Stock
Footnotes (1)
- [F1]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.